NEW HAVEN, Conn.--(BUSINESS WIRE)--Applied Spine Technologies (AST) Inc. (www.appliedspine.com) announced today that Triangle Orthopaedic Associates and North Carolina Specialty Hospital (NCSH), an acute care facility located in Durham, N.C., are the first in the U.S. to implant the Company’s Stabilimax NZ Dynamic Spine Stabilization System as part of a randomized, controlled clinical trial, which will compare posterior dynamic stabilization using the Stabilimax NZ to patients receiving traditional fusion stabilization to treat degenerative lumbar spinal stenosis. A total of 266 Stabilimax NZ patients and 133 ‘control’ patients are expected to be enrolled in all of the trials.
